COCRYSTAL PHARMA, INC. Assets, Fair Value Disclosure
COCRYSTAL PHARMA, INC. (COCP) had Assets, Fair Value Disclosure of $1.34 million as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2017-11-08
- 2017-09-30: Assets, Fair Value Disclosure $1.34M.
- 2016-12-31: Assets, Fair Value Disclosure $3.64M.
- 2016-09-30: Assets, Fair Value Disclosure $5.91M.
- 2016-06-30: Assets, Fair Value Disclosure $5.02M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2017-09-30 | $1.34M 10-Q · filed 2017-11-08 |
| 2016-12-31 | $3.64M 10-Q · filed 2017-11-08 |
| 2016-09-30 | $5.91M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $5.02M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $10.24M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $9.28M 10-Q · filed 2016-11-09 |
| 2015-09-30 | $12.41M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $15.78M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $993.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $5.95M 10-K · filed 2016-03-15 |
| 2013-12-31 | $1.03M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |